Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

Clinical trial NCT02858401 · COMPLETED

Trial details

NCT number: NCT02858401
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2015-01-29
Primary completion: 2019-02-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.